BNT411 | MedChemExpress (MCE)
BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro. BNT411 has anticancer activity and can be used in cancer research, including non-small cell lung cancer, pancreatic cancer, and untreated extensive-stage small cell lung cancer (ES-SCLC)[1].
| Trivial name | BNT411 |
| Catalog Number | HY-160715 |
| Research Area | Cancer |
| CAS# | 2296821-50-4 |
| Purity | ≥98.0% |
| SMILES | O=C(C)N(C1CCOCC1)CCCCN2C(CCOC)=NC3=C2C4=C(C=CC=C4)N=C3N |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/bnt411.html |